-
1Academic Journal
المؤلفون: I. Shardakov, A. Shestakov, I. Glot, V. Epin, G. Gusev, R. Tsvetkov
المصدر: Fracture and Structural Integrity, Vol 16, Iss 62, Pp 561-572 (2022)
مصطلحات موضوعية: fiber bragg grating, sensor calibration, temperature compensation, quadratic approximation, Mechanical engineering and machinery, TJ1-1570, Structural engineering (General), TA630-695
وصف الملف: electronic resource
-
2Academic Journal
المؤلفون: V. Matveenko, I. Shardakov, T. Korepanova
المصدر: Fracture and Structural Integrity, Vol 13, Iss 49, Pp 225-242 (2019)
مصطلحات موضوعية: Stress singularity, Conical bodies, Eigensolutions, Mechanical engineering and machinery, TJ1-1570, Structural engineering (General), TA630-695
وصف الملف: electronic resource
-
3Academic Journal
المؤلفون: I. Shardakov,, A. Shestakov, R. Tsvetkov, I. Glot
المصدر: Fracture and Structural Integrity, Vol 12, Iss 46, Pp 383-390 (2018)
مصطلحات موضوعية: Vibration-based diagnostics, RC structure, Cracks, Full-scale model, Experiment, Simulation., Mechanical engineering and machinery, TJ1-1570, Structural engineering (General), TA630-695
وصف الملف: electronic resource
-
4Academic Journal
المؤلفون: A. Kulesh A., V. Drobakha E., K. Sobyanin V., S. Kulikova P., A. Bykova Yu., N. Kaileva A., A. Monak A., I. Shardakov N., V. Shestakov V., А. Кулеш А., В. Дробаха Е., К. Собянин В., С. Куликова П., А. Быкова Ю., Н. Кайлева А., А. Монак А., И. Шардаков Н., В. Шестаков В.
المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 11, No 3 (2019); 26-34 ; Неврология, нейропсихиатрия, психосоматика; Vol 11, No 3 (2019); 26-34 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2019-3
مصطلحات موضوعية: ischemic stroke, diffusion-weighted magnetic resonance imaging, fractional anisotropy, rehabilitation potential, ишемический инсульт, диффузионно-взвешенная магнитно-резонансная томография, фракционная анизотропия, реабилитационный потенциал
وصف الملف: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/1169/924; https://nnp.ima-press.net/nnp/article/view/1169/925; Puig J, Blasco G, Schlaug G, et al. Diffusion tensor imaging as a prognostic biomarker for motor recovery and rehabilitation after stroke. Neuroradiology. 2017 Apr;59(4):343-351. doi:10.1007/s00234-017-1816-0. Epub 2017 Mar 14.; Stebbins GT, Murphy CM. Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment. Behav Neurol. 2009;21(1): 39-49. doi:10.3233/BEN-2009-0234.; Lindenberg R, Renga V, Zhu LL, et al. Structural integrity of corticospinal motor fibers predicts motor impairment in chronic stroke. Neurology. 2010 Jan 26;74(4):280-7. doi:10.1212/WNL.0b013e3181ccc6d9.; Park CH, Kou N, Boudrias MH, et al. Assessing a standardised approach to measuring corticospinal integrity after stroke with DTI. Neuroimage Clin. 2013 Apr 11;2:521-33. doi:10.1016/j.nicl.2013.04.002. eCollection 2013.; Song J, Nair VA, Young BM, et al. DTI measures track and predict motor function outcomes in stroke rehabilitation utilizing BCI technology. Front Hum Neurosci. 2015 Apr 27; 9:195. doi:10.3389/fnhum.2015.00195. eCollection 2015.; Puig J, Pedraza S, Blasco G, et al. Wallerian degeneration in the corticospinal tract evaluated by diffusion tensor imaging correlates with motor deficit 30 days after middle cerebral artery ischemic stroke. AJNR Am J Neuroradiol. 2010 Aug;31(7):1324-30. doi:10.3174/ajnr.A2038. Epub 2010 Mar 18.; Thomalla G, Glauche V, Koch MA, et al. Diffusion tensor imaging detects early Wallerian degeneration of the pyramidal tract after ischemic stroke. Neuroimage. 2004 Aug;22(4): 1767-74.; Stinear CM, Barber PA, Petoe M, et al. The PREP algorithm predicts potential for upper limb recovery after stroke. Brain. 2012 Aug;135(Pt 8):2527-35. doi:10.1093/brain/aws146. Epub 2012 Jun 10.; Stinear CM, Byblow WD, Ackerley SJ, et al. PREP2: A biomarker-based algorithm for predicting upper limb function after stroke. Ann Clin Transl Neurol. 2017 Oct 24;4(11):811-820. doi:10.1002/acn3.488. eCollection 2017 Nov.; Kim SH, Jang SH. Prediction of aphasia outcome using diffusion tensor tractography for arcuate fasciculus in stroke. AJNR Am J Neuroradiol. 2013 Apr;34(4):785-90. doi:10.3174/ajnr.A3259. Epub 2012 Oct 4.; Kulesh A, Drobakha V, Kuklina E, et al. Tract-Specific Fractional Anisotropy, and Brain Morphometry in Post-Stroke Cognitive Impairment. J Stroke Cerebrovasc Dis. 2018 Jul;27(7):1752-1759. doi:10.1016/j.jstrokecerebrovasdis.2018.02.004. Epub 2018 Mar 30.; Кулеш АА, Дробаха ВЕ, Куклина ЕМ и др. Когнитивная траектория пациентов в восстановительном периоде ишемического инсульта: роль нейровоспаления и структурных церебральных факторов. Казанский медицинский журнал. 2017;(4):513-8. doi:10.17750/KMJ2017-513.; Baron RM, Kenny DA. The moderator– mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986 Dec;51(6):1173-82.; Mandonnet E, Sarubbo S, Petit L. The Nomenclature of Human White Matter Association Pathways: Proposal for a Systematic Taxonomic Anatomical Classification. Front Neuroanat. 2018 Nov 6;12:94. doi:10.3389/ fnana.2018.00094. eCollection 2018.; Schiemanck SK, Kwakkel G, Post MW, et al. Predictive value of ischemic lesion volume assessed with magnetic resonance imaging for neurological deficits and functional outcome poststroke: A critical review of the literature. Neurorehabil Neural Repair. 2006 Dec;20(4): 492-502. doi:10.1177/1545968306289298.; Schmahmann JD, Pandya DN, Wang R, et al. Association fibre pathways of the brain: parallel observations from diffusion spectrum imaging and autoradiography. Brain. 2007 Mar; 130(Pt 3):630-53. Epub 2007 Feb 9. doi:10.1093/brain/awl359.; Jang SH, Jang WH. Ideomotor Apraxia Due to Injury of the Superior Longitudinal Fasciculus. Am J Phys Med Rehabil. 2016 Aug; 95(8):e117-20. doi:10.1097/PHM.0000000000000483.; Jang SH, Chang CH, Jung YJ, et al. Bilateral injury of the superior longitudinal fasciculus in a patient with Balint syndrome. Neurology. 2016 Oct 4;87(14):1519-1520.; Koyama T, Domen K. Diffusion Tensor Fractional Anisotropy in the Superior Longitudinal Fasciculus Correlates with Functional Independence Measure Cognition Scores in Patients with Cerebral Infarction. J Stroke Cerebrovasc Dis. 2017 Aug;26(8): 1704-1711. doi:10.1016/j.jstrokecerebrovasdis.2017.03.034. Epub 2017 May 3.; Ramsey LE, Siegel JS, Lang CE, et al. Behavioural clusters and predictors of performance during recovery from stroke. Nat Hum Behav. 2017;1. pii: 0038. doi:10.1038/s41562-016-0038. Epub 2017 Feb 17.; Dong G, Li H, Potenza MN. Short-Term Internet-Search Training Is Associated with Increased Fractional Anisotropy in the Superior Longitudinal Fasciculus in the Parietal Lobe. Front Neurosci. 2017 Jun 29;11:372. doi:10.3389/fnins.2017.00372. eCollection 2017.; Bubb EJ, Metzler-Baddeley C, Aggleton JP. The cingulum bundle: Anatomy, function, and dysfunction. Neurosci Biobehav Rev. 2018 Sep; 92:104-127. doi:10.1016/j.neubiorev.2018. 05.008. Epub 2018 May 16.; Lebel C, Gee M, Camicioli R, et al. Diffusion tensor imaging of white matter tract evolution over the lifespan. Neuroimage. 2012 Mar;60(1):340-52. doi:10.1016/j.neuroimage.2011.11.094. Epub 2011 Dec 8.; Santiago C, Herrmann N, Swardfager W, et al. White Matter Microstructural Integrity Is Associated with Executive Function and Processing Speed in Older Adults with Coronary Artery Disease. Am J Geriatr Psychiatry. 2015 Jul;23(7):754-63. doi:10.1016/j.jagp.2014.09.008. Epub 2014 Sep 28.; Cox SR, Ritchie SJ, Tucker-Drob EM, et al. Ageing and brain white matter structure in 3,513 UK Biobank participants. Nat Commun. 2016 Dec 15;7:13629. doi:10.1038/ncomms13629.; Кайлева НА, Кулеш АА, Горст НХ и др. Роль интактного полушария в определении реабилитационного потенциала в остром периоде ишемического инсульта: диффузионно-перфузионная модель. Неврология, нейропсихиатрия, психосоматика. 2019; 11(1):28-35. doi:10.14412/2074-2711-2019-1-28-35.; Nanda P, Banks GP, Pathak YJ, et al. Connectivity-based parcellation of the anterior limb of the internal capsule. Hum Brain Mapp. 2017 Dec;38(12):6107-6117. doi:10.1002/hbm.23815. Epub 2017 Sep 14.; Кулеш АА, Кайлева НА, Горст НХ и др. Связь между интегральной оценкой магнитно-резонансных маркеров церебральной болезни мелких сосудов, клиническим и функциональным статусом в остром периоде ишемического инсульта. Неврология, нейропсихиатрия, психосоматика. 2018; 10(1):24-31. doi:10.14412/ 2074-2711-2018-1-24-31; Кулеш АА, Дробаха ВЕ, Шестаков ВВ. Церебральная спорадическая неамилоидная микроангиопатия: патогенез, диагностика и особенности лечебной тактики. Неврология, нейропсихиатрия, психосоматика. 2018; 10(4):13-22. doi:10.14412/2074-2711-2018-4-13-22.; Парфенов ВА, Остроумова ТМ, Остроумова ОД и др. Диффузионно-тензорная магнитно-резонансная томография в диагностике поражения белого вещества головного мозга у пациентов среднего возраста с неосложненной эссенциальной артериальной гипертензией. Неврология, нейропсихиатрия, психосоматика. 2018;10(2):20-6. doi:10.14412/2074-2711-2018-2-20-26; Granziera C, Ay H, Koniak SP, et al. Diffusion tensor imaging shows structural remodeling of stroke mirror region: results from a pilot study. Eur Neurol. 2012;67(6):370-6. doi:10.1159/000336062. Epub 2012 May 17.; Murase N, Duque J, Mazzocchio R, et al. Influence of interhemispheric interactions on motor function in chronic stroke. Ann Neurol. 2004 Mar;55(3):400-9. doi:10.1002/ana.10848.; Tuch DS, Salat DH, Wisco JJ, et al. Choice reaction time performance correlates with diffusion anisotropy in white matter pathways supporting visuospatial attention. Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12212-7. Epub 2005 Aug 15. doi:10.1073/pnas.0407259102.; https://nnp.ima-press.net/nnp/article/view/1169
-
5
المؤلفون: I. Shardakov, Y. Ivanov, V. Chudinov, I. Glot, T. Timkina
المصدر: Procedia Structural Integrity. 37:1065-1072
مصطلحات موضوعية: Earth-Surface Processes
-
6
المؤلفون: G. Gusev, I. Shardakov
المصدر: Procedia Structural Integrity. 37:425-430
مصطلحات موضوعية: Earth-Surface Processes
-
7Academic Journal
المؤلفون: E. L. Nazarova, E. E. Sukhorukova, N. V. Minaeva, V. I. Shardakov, E. S. Fokina, Е. Л. Назарова, Э. Е. Сухорукова, Н. В. Минаева, В. И. Шардаков, Е. С. Фокина
المصدر: Medical Immunology (Russia); Том 20, № 4 (2018); 523-534 ; Медицинская иммунология; Том 20, № 4 (2018); 523-534 ; 2313-741X ; 1563-0625 ; 10.15789/1563-0625-2018-4
مصطلحات موضوعية: эффективность лечения, rituximab, gene polymorphism, immune response, interleukin-10, treatment efficacy, ритуксимаб, полиморфизм генов, иммунный ответ, интерлейкин-10
وصف الملف: application/pdf
Relation: https://www.mimmun.ru/mimmun/article/view/1560/1047; Назарова Е.Л., Шардаков В.И., Демьянова В.Т., Докшина И.А., Зотина Е.Н. Модификации генов иммунного ответа при различных типах течения хронического лимфолейкоза // Ученые записки СПбГМУ им. акад. И.П. Павлова, 2015. Т. XXII, № 1. С. 21-24. [Nazarova E.L., Shardakov V.I., Demyanova V.T., Dokshina I.A., Zotina E.N. Modification of immune response genes in various types of chronic lymphocytic leukemia. Uchenye zapiski SPbGMU im. akad. I.P. Pavlova = Record of the I.P. Pavlov St. Petersburg State Medical University, 2015, Vol. XXII, no. 1, pp. 21-24. (In Russ.)]; Aklilu M., Stadler W.M., Markiewicz M., Vogelzang N.J., Mahowald M., Johnson M., Gajewski T.F. Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma. Ann. Oncol., 2004, Vol. 15, no. 7, pp. 1109-1114.; Alas S., Bonavida B. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin’s lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis. Clin. Cancer Res., 2003, Vol. 9, no. 1, pp. 316-326.; Alas S., Bonavida B. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin’s lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res., 2001, Vol. 61, no. 13, pp. 5137-5144.; Alas S., Emmanouilides C., Bonavida B. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin’s lymphoma to apoptosis. Clin. Cancer Res., 2001, Vol. 7, no. 3, pp. 709-723.; Baran W., Szepietowski J.C., Mazur G., Baran E. IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris. Acta Derm. Venereol., 2008, Vol. 88, no. 2, pp. 113-116.; Béguelin W., Sawh S., Chambwe N., Chan F.C., Jiang Y., Choo J.-W., Scott D.W., Chalmers A., Geng H., Tsikitas L., Tam W., Bhagat W., Gascoyne R.D., Shaknovich R. IL-10 receptor is a novel therapeutic target in DLBCLs. Leukemia, 2015, Vol. 29, no. 8, pp. 1-11.; Binet J.L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., Vaugier G., Potron G., Colona P., Oberling F., Thomas M., Tchernia G., Jacquillat C., Boivin P., Lesty C., Duault M.T., Monconduit M., Belabbes S., Gremy F. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 1981, Vol. 48, no. 1, pp. 198-206.; Blay J.Y., Burdin N., Rousset F., Lenoir G., Biron P., Philip T., Banchereau J., Favrot M.C. Serum interleukin-10 in non-Hodgkin’s lymphoma: a prognostic factor. Blood, 1993, Vol. 82, no. 7, pp. 2169-2174.; Cartron G., Watier H., Golay J., Solal-Celigny P. From the bench to the bedside: ways to improve rituximab efficacy. Blood, 2004, Vol. 104, no. 9, pp. 2635-2642.; Chen Y., Zheng T., Lan Q., Foss F., Kim C., Chen X., Dai M., Li Y., Holford T., Leaderer B., Boyle P., Chanock S.J., Rothman N., Zhang Y. Cytokine polymorphisms in Th1/Th 2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma. Blood, 2011, Vol. 117, no. 2, pp. 585-590.; de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-b produced by monocytes. J. Exp. Med., 1991, Vol. 174, no. 5, pp. 1209-1220.; Domen J., Gandy K.L., Weissman I.L. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood, 1998, Vol. 91, no. 7, pp. 2272–2282.; Domingo-Domènech E., Benavente Y., González-Barca E., Montalban C., Gumà J., Bosch R., Wang S.S., Lan Q., Whitby D., Fernández de Sevilla A., Rothman N., de Sanjosé S. Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms. Haematologica, 2007, Vol. 92, no. 11, pp. 1475-1481.; Falduto A., Cimino F., Speciale A., Musolino C., Gangemi S., Saija A., Allegra A. How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma. Blood Rev., 2017, Vol. 31, no. 4, pp. 235-249.; Fayad L., Keating M.J., Reuben J.M., O’Brien S., Lee B.N., Lerner S., Kurzrock R. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood, 2001, Vol. 97, no. 1, pp. 256-263.; Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones. J. Exp. Med., 1989, Vol. 170, no. 6, pp. 2081-2095.; Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., O’Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol., 1991, Vol. 146, no. 10, pp. 3444-3451.; Gagez A.L., Tuaillon E., Cezar R., Dartigeas C., Mahé B., Letestu R., Maisonneuve H., Gouilleux-Gruart V., Bollore K., Ferrant E., Aurran T., Feugier P., Leprêtre S., Cartron G. Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups. Blood Cancer J., 2016, Vol. 6, e389. doi:10.1038/bcj.2015.115.; Habermann T.M., Wang S.S., Maurer M.J., Morton L.M., Lynch C.F., Ansell S.M., Hartge P., Severson R.K., Rothman N., Davis S., Geyer S.M., Cozen W., Chanock S.J., Cerhan J.R. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. Blood, 2008, Vol. 112, no. 7, pp. 2694-2702.; Hohaus S., Giachelia M., di Febo A., Martini M., Massini G., Vannata B., D’Alo’ F., Guidi F., Greco M., Pierconti F., Larocca L.M., Voso M.T., Leone G. Polymorphism in cytokine genes as prognostic markers in Hodgkin’s lymphoma. Ann. Oncol., 2007, Vol. 18, no. 8, pp. 1376-1381.; Huang S.J., Lee L.J., Gerrie A.S., Gillan T.L., Bruyere H., Hrynchak M., Smith A.C., Karsan A., Ramadan K.M., Jayasundara K.S., Toze C.L. Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada. Leuk. Res., 2017, Vol. 55, pp. 79-90.; Jamroziak K., Puła B., Walewski J. Current treatment of chronic lymphocytic leukemia. Curr. Treat. Options Oncol., 2017, Vol. 18, no. 1, p. 5.; Kim M.K., Yoon K.-A., Park E.Y., Joo J., Lee E.Y., Eom H.-S., Kong S.-Y. Interleukin-10 polymorphisms in association with prognosis in patients with B-cell lymphoma treated by R-CHOP. Genomics Inform., 2016, Vol. 14, no. 4, pp. 205-210.; Kube D., Hua T.D., von Bonin F., Schoof N., Zeynalova S., Klöss M., Gocht D., Potthoff B., Tzvetkov M., Brockmöller J., Löffler M., Pfreundschuh M., Trümper L. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin’s lymphoma: an exploratory study. Clin. Cancer Res., 2008, Vol. 14, no. 12, pp. 3777-3784.; Lan Q., Zheng T., Rothman N., Zhang Y., Wang S.S., Shen M., Berndt S.I., Zahm S.H., Holford T.R., Leaderer B., Yeager M., Welch R., Boyle P., Zhang B., Zou K., Zhu Y., Chanock S. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood, 2006, Vol. 107, no. 10, pp. 4101-4108.; Lech-Maranda E., Baseggio L., Bienvenu J., Charlot C., Berger F., Rigal D., Warzocha K., Coiffier B., Salles G. Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood, 2004, Vol. 103, no. 9, pp. 3529-3534.; Lech-Maranda E., Baseggio L., Charlot C., Rigal D., Berger F., Jamroziak K., Warzocha K., Coiffier B., Salles G. Genetic polymorphisms in the proximal IL-10 promoter and susceptibility to non-Hodgkin lymphoma. Leuk. Lymphoma, 2007, Vol. 48, no. 11, pp. 2235-2238.; Miyazaki I., Cheung R.K., Dosch H.M. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein–Barr virus. J. Exp. Med., 1993, Vol. 178, no. 2, pp. 439-447.; O’Garra A., Stapleton G., Dhar V., Pearce M., Schumacher J., Rugo H., Barbis D., Stall A., Cupp J., Moore K., Vieira P., Mosmann T., Whitmore A., Arnold L., Haughton G., Howard M. Production of cytokines by mouse B cell: B lymphomas and normal B cells produce interleukin 10. Int. Immunol., 1990, Vol. 2, no. 9, pp. 821-832.; Pang N., Zhang R., Li J., Zhang Z., Yuan H., Chen G., Zhao F., Wang L., Cao H., Qu J., Ding J. Increased IL-10/IL-17 ratio is aggravated along with the prognosis of patients with chronic lymphocytic leukemia. Int. Immunopharmacol., 2016, Vol. 40, pp. 57-64.; Qiu H., Li J., Feng Z., Yuan J., Lu J., Hu X., Gao L., Lv S., Yang J., Chen L. CD19(+) CD20(-) CD27(hi) IL-s10-producing B cells are overrepresented in R-CHOP-treated DLBCL patients in complete remission. Clin. Exp. Pharmacol. Physiol., 2016, Vol. 43, no. 9, pp. 795-801.; Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., Pasternack B.S. Clinical staging of chronic lymphocytic leukemia. Blood, 1975, Vol. 46, no. 2, pp. 219-234.; Reed J.C. Bcl-2 family proteins: regulators of chemoresistance in cancer. Toxicol. Lett., 1995, Vol. 82-83, pp. 155-158.; Rousset F., Garcia E., Defrance T., Peronne C., Vezzio N., Hsu D.H., Kastelein R., Moore K.W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Immunology, 1992, Vol. 89, no. 5, pp. 1890-1893.; Sarris A.H., Kliche K.O., Pethambaram P., Preti A., Tucker S., Jackow C., Messina O., Pugh W., Hagemeister F.B., McLaughlin P., Rodriguez M.A., Romaguera J., Fritsche H., Witzig T., Duvic M., Andreeff M., Cabanillas F. Interleukin-10 levels are often elevated in serum of adults with Hodgkin’s disease and are associated with inferior failure-free survival. Ann. Oncol., 1999, Vol. 10, no. 4, pp. 433-440.; Shapiro-Shelef M., Calame K. Regulation of plasma-cell development. Nat. Rev. Immunol., 2005, Vol. 5, no. 3, pp. 230-242.; Tarabar O., Cikota-Aleksić B., Tukić L., Milanović N., Aleksić A., Magić Z. Association of interleukin-10, tumor necrosis factor-a and transforming growth factor-β gene polymorphisms with the outcome of diffuse large B-cell lymphomas. Int. J. Clin. Oncol., 2014, Vol. 19, no. 1, pp. 186-192.; Tsujimoto Y. Stress-resistance conferred by high level of bcl-2 a protein in human B lymphoblastoid cell. Oncogene, 1989, Vol. 4, no. 11, pp. 1331-1336.; Weber-Nordt R.M., Henschler R., Schott E., Wehinger J., Behringer D., Mertelsmann R., Finke J. Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells. Blood, 1996, Vol. 88, no. 7, pp. 2549-2558.; https://www.mimmun.ru/mimmun/article/view/1560
-
8Academic Journal
المؤلفون: E. L. Nazarova, V. I. Shardakov
المصدر: Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 24, Iss 3, Pp 7-21 (2017)
مصطلحات موضوعية: lymphoma, leukemia, multiple myeloma, toll-like receptors, gene polymorphism, Medicine (General), R5-920
Relation: https://www.sci-notes.ru/jour/article/view/427; https://doaj.org/toc/1607-4181; https://doaj.org/article/3c453a4d6d9b4fc891e24ba39a015d7f
-
9Academic Journal
المؤلفون: E. N. Zotina, T. P. Zagoskina, V. I. Shardakov, A. V. Yovdy, G. A. Zaitseva
المصدر: Медицинская иммунология, Vol 18, Iss 5, Pp 489-494 (2016)
مصطلحات موضوعية: chronic lymphocytic leukemia, cytokines, tumor necrosis factor-alpha, prognosis, overall survival, Immunologic diseases. Allergy, RC581-607
Relation: https://www.mimmun.ru/mimmun/article/view/1075; https://doaj.org/toc/1563-0625; https://doaj.org/toc/2313-741X; https://doaj.org/article/21ce1f035d114e6182dde3c3631951f2
-
10Academic Journal
المؤلفون: E. L. Nazarova, V. I. Shardakov, V. T. Dem’Yanova, I. A. Dokshina, E. N. Zotina, Е. Л. Назарова, В. И. Шардаков, В. Т. Демьянова, И. А. Докшина, Е. Н. Зотина
المصدر: The Scientific Notes of the Pavlov University; Том 22, № 1 (2015); 21-24 ; Учёные записки Первого Санкт-Петербургского государственного медицинского университета имени академика И. П. Павлова; Том 22, № 1 (2015); 21-24 ; 2541-8807 ; 1607-4181 ; 10.24884/1607-4181-2015-22-1
مصطلحات موضوعية: Toll-like receptor, полиморфизм генов, иммунный ответ, цитокины, толлподобные рецепторы, chronic lymphocytic leukemia, gene polymorphism, immune response, cytokines
وصف الملف: application/pdf
Relation: https://www.sci-notes.ru/jour/article/view/104/102; Батожаргалова Б. Ц. Клинико-эпидемиологические, генетические и этнические особенности бронхиальной астмы у подростков Забайкалья: дис. д-ра мед. наук. - М., 2013. - 284 с.; Воропаева Е. Н. Клиническое значение делеции гена CCR5 у больных неходжкинскими злокачественными лимфомами / Е. Н. Воропаева, Н. В. Скворцова, М. И. Воевода, З. В. Тарновский // Бюллетень СО РАМН. - 2011. -№ 2. - С. 26-30.; Иванов А. М., Камилова Т. А., Никитин В. Ю. и др. Полиморфизм рецепторов врожденного иммунитета // Вестник Росс. военно-мед. акад. - 2009. - № 1. - С. 172-84.; Овсепян В. А., Росин В. А., Баранчикова С. В. Возможная ассоциация полиморфизма генов ферментов биотрансформации ксенобиотиков с хромосомными нарушениями при хроническом лимфолейкозе // Вестник гематол. - 2013. - № 9 (2). - С. 40-41.; Росин В. А. Полиморфизм генов биотрансформации ксенобиотиков CYP1A1, GSTM1, GSTT1, GSTP1 у больных хроническим лимфолейкозом: автореф. дис. канд. мед. наук. - СПб., 2010. - 22 с.; Bidwell J., Keen L., Gallagher G. et al. Cytokine gene polymorphism in human disease: on-line database // Genes Immun. -1999. - № 1 (1). - Р. 3-19.; Binet J. L., Auquier A., Dighiero G. et al. A new Prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis // Cancer. - 1981. -№ 48 (1). - Р. 198-206.; Cerhan J. R., Wang S., Maurer M. J. et al. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival // Blood. - 2007. -№ 109 (12). - Р. 5439-5446.; Chen G.-B., Xu Y., Xu H.-M. et al. Practical and theoretical considerations in study design for detecting gene-gene interactions using MDR and GMDR approaches // PLoS ONE. - 2011. - № 6 (2). - Р. e16981.; El-Omar E. M., Ng M. T., Hold G. L. Polymorphisms in Toll-like receptor genes and risk of cancer // Oncogene. -2008. - № 27 (2). - Р. 244-252.; Forrest M. S., Skibola C. F., Lightfoot T. J. et al. Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma // Br. J. Haematol. - 2006. - № 134 (2). - Р. 180-183.; Kutikhin A. G. Association of polymorphism in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk // Hum. Immunol. - 2011. - № 72 (11). -Р. 1095- 116.; Lou X. Y., Chen G.-B., Yan L. et al. A generalized combinatorial approach for detecting gene-by-gene and geneby-environment interactions with application to nicotine dependence // Am. J. Hum. Genet. - 2007. - № 80 (6). -Р. 1125- 1137.; Morton L. M., Wang S. S., Cozen W. et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes // Blood. - 2008. - № 112 (13). - Р. 5150-5160.; National Center for Biotechnology Information. URL: http:// www. ncbi. nlm. nih. gov/.; National Human Genome Research Institute. URL: https:// www. genome. gov/.; Purdue M. P., Lan Q., Wang S. S. et al. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma // Carcinogenesis. - 2009. - № 30 (2). -Р. 275-281.; Ritchie M. D., Hahn L. W., Roodi N. et al. Multifactor-Dimensionality Reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer // Am. J. Hum. Genet. - 2001. - № 69 (1). - Р. 138-147.; Vangsted A., Klausen T. W., Vogel U. Genetic mutations in multiple myeloma I: effect on risk of multiple myeloma // Eur. J. Haematol. - 2012. - № 88 (1). - Р. 8-30.; https://www.sci-notes.ru/jour/article/view/104
-
11Academic Journal
المؤلفون: M. P. Рlyasunova, S. V. Chlybova, A. A. Feoktistov, V. I. Shardakov
المصدر: Медицинская иммунология, Vol 16, Iss 6, Pp 587-592 (2015)
مصطلحات موضوعية: chronic endometritis, cytotoxic lymphocytes, physiotherapy, Immunologic diseases. Allergy, RC581-607
Relation: https://www.mimmun.ru/mimmun/article/view/772; https://doaj.org/toc/1563-0625; https://doaj.org/toc/2313-741X; https://doaj.org/article/883fa2e7f15b4aca93138dc788952de3
-
12Academic Journal
المؤلفون: M. N Khorobrykh, T. P. Zagoskina, V. I. Shardakov, E. L. Nazarova, A. V. Yovdiy, М. Н. Хоробрых, Т. П. Загоскина, В. И. Шардаков, Е. Л. Назарова, А. В. Йовдий
المصدر: Medical Immunology (Russia); Том 12, № 4-5 (2010); 447-452 ; Медицинская иммунология; Том 12, № 4-5 (2010); 447-452 ; 2313-741X ; 1563-0625 ; 10.15789/1563-0625-2010-4-5
مصطلحات موضوعية: СD52, cytokines, lymphocyte subsets, alemtuzumab, CD52, цитокины, алемтузумаб
وصف الملف: application/pdf
Relation: https://www.mimmun.ru/mimmun/article/view/408/411; Баранчук Н.В. Сравнительная оценка показателей иммунитета и иммунофенотипа лимфоидных клеток у больных лимфопролиферативными заболеваниями: Автореф. дисс. … канд. мед. наук. -Пермь, 2003. -17 с.; Бережная Н.М. Система интерлейкинов и рак. -Киев, 2000. -224 с.; Воробьев А.И. Руководство по гематологии: Учебник для вузов. -М.: Ньюдиамед, 2003. -Т. 2. -256 c.; Грачева Л.А. Цитокины в онкогематологии. -М.: Алтус, 1996. -58 c.; Лебедев К.А., Понякина И.Д. Иммунологическая недостаточность (выявление и лечение). -М.: Медицинская книга; Н. Новгород: Изд-во НГМА, 2003. -443 с.; Ляликова Г.В., Виноградова Ю.Е. Содержание отдельных классов иммуноглобулинов в сыворотке и слюне больных с различными стадиями хронического лимфолейкоза//Тер. Арх. -1986. -№ 9. -С. 77-80.; Потапов М.П. В-лимфоциты. Цитокинобразующая функция//Иммунология. -1994. -№ 4. -С. 4; Рукавицын О.А., Поп В.П. Хронические лейкозы. -М.: БИНОМ. Лаборатория знаний, 2004. -240 с.; Серебряная Н.Б., Новик А.А., Волошин С.В. Клиническое значение некоторых цитокинов при злокачественных неходжкинских лимфомах//Цитокины и воспаление. -2002. -№ 3. -С. 52; Симбирцев А.С. Цитокины -новая система регуляции защитных реакций организма//Цитокины и воспаление. -2003. -№ 1. -С. 16; Тугуз А.Р. Динамика содержания TNFα, IL-1β, IL-6, IL-4 и IL-8 в раннем послеоперационном периоде у больных раком желудка // Иммунология. - 2002. - Т. 23, № 1. - С. 59; Dumont FJ. CAMPATH (alemtuzumab) for the treatment of chronic lymphocytic leukemia and beyond // Expert Rev Anticancer Ther. - 2002. - Р. 23-25.; Hale G., Waldmann H. From laboratory to clinic: the story of CAMPATH-1//In: George AJT, Urch C, eds. Antibodies in the Clinic: Methods in Molecular Medicine. -2000. -Vol. 40: Diagnostic and Therapeutic Antibodies. Humana Press, NJ. -Р. 243-266.; Hale G. CD52//J Biol Regul Homeost Agents. -2002. -Р. 386-391.; Seiler T., Dohner H., Stingelbauer S. Risk stratification in Chronic Lymphocytic Leukemia//Semin. Oncol. -2006. -Vol. 33. -Р. 186-194.; https://www.mimmun.ru/mimmun/article/view/408
-
13Academic Journal
المؤلفون: E. L. Nazarova, V. I. Shardakov, V. T. Demyanova, T. P. Zagoskina, E. N. Zotina, Е. Л. Назарова, В. И. Шардаков, В. Т. Демьянова, Т. П. Загоскина, Е. Н. Зотина
المصدر: Medical Immunology (Russia); Том 16, № 5 (2014); 431-436 ; Медицинская иммунология; Том 16, № 5 (2014); 431-436 ; 2313-741X ; 1563-0625 ; 10.15789/1563-0625-2014-5
مصطلحات موضوعية: рецепторы, gene polymorphism, cytokines, cytokine receptors, полиморфизм генов, цитокины
وصف الملف: application/pdf
Relation: https://www.mimmun.ru/mimmun/article/view/729/715; Гончарова И.А., Белобородова Е.В., Фрейдин М.Б., Белобородова Э.И., Черногорюк Г.Э., Пузырев В.П. Ассоциация полиморфных маркеров генов иммунной системы с количественными признаками, патогенетически значимыми для хронического вирусного гепатита // Молекулярная биология. 2008. Т. 42, № 2. С. 242-246. [Goncharova I.A., Beloborodova E.V., Freydin M.B., Beloborodova E.I., Chernogoryuk G.E., Puzyrev V.P. Assotsiatsiya polimorfnykh markerov genov immunnoy sistemy s kolichestvennymi priznakami, patogeneticheski znachimymi dlya khronicheskogo virusnogo gepatita [Association of polymorphic markers of immune system genes with quantitative features important for the pathogenesis of chronic viral hepatitis]. Molekulyarnaya biologiya = Molecular Biology, 2008, Vol. 42, no. 2, pp. 242-246].; Bidwell J., Keen L., Gallagher G., Kimberly R., Huizinga T., McDermott M.F., Oksenberg J., McNicholl J., Pociot F., Hardt C., D’Alfonso S. Cytokine gene polymorphism in human disease: on-line databases. Genes and Immunity, 1999, Vol. 1, no. 1, pp. 3-19.; Honore P., Wade C.L., Zhong C., Harris R.R., Wu C., Ghayur T., Iwakura Y., Decker M.W., Faltynek C., Sullivan J., Jarvis M.F. Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain. Behav. Brain Res., 2006, Vol. 167, no. 2, pp. 355-364.; Jin P., Panelli M.C., Marincola F.M., Wang E. Cytokine polymorphism and its possible impact on cancer. Immunol. Res., 2004, Vol. 30, no. 2, pp. 181-190.; Kurzrock R. Cytokine deregulation in cancer. Biomed. Pharmacother., 2001, Vol. 55, no. 9-10, pp. 543-547.; McCulley M.C., Day I.N., Holmes C. Association between interleukin 1-beta promoter (-511) polymorphism and depressive symptoms in Alzheimer’s disease. Am. J. Med. Genet. B Neuropsychiatr. Genet., 2004, Vol. 124B, no. 1, pp. 50-53.; Milligan E.D., Sloane E.M., Langer S.J., Hughes T.S., Jekich B.M., Frank M.G., Mahoney J.H., Levkoff L.H., Maier S.F., Cruz P.E., Flotte T.R., Johnson K.W., Mahoney M.M., Chavez R.A., Leinwand L.A., Watkins L.R. Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain, 2006, Vol. 126, no. 1-3, pp. 294-308.; Reyes-Gibby C.C., Spitz M., Wu X., Merriman K., Etzel C., Bruera E., Kurzrock R., Shete S. Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-alpha-308 G/A IL6-174G/G and IL- 8251T/A. Cancer Epidemiol. Biomarkers Prev., 2007, Vol. 16, no. 12, pp. 2745-2751.; Reyes-Gibby C.C., Wu X., Spitz M., Kurzrock R., Fisch M., Bruera E., Shete S. Molecular epidemiology, cancer-related symptoms, and cytokine pathway. Lancet Oncol., 2008, Vol. 9, no. 8, pp. 777-785.; Spitz M.R., Wu X., Mills G. Intergative epidemiology: from risk assesment to outcome prediction. J. Clin. Oncol., 2005, Vol. 23, no. 2, pp. 267-275.; Uceyler N., Eberle T., Rolke R., Birklein F., Sommer C. Differential expression patterns of cytokines in complex regional pain syndrome. Pain, 2007, Vol. 132, no. 1-2, pp. 195-205.; Wang L., Jiang Y., Zhang Y., Wang Y., Huang S., Wang Z., Tian B., Yang Y., Jiang W., Pang D. Association Analysis of IL-17A and IL-17F Polymorphisms in Chinese Han Women with Breast Cancer. PLoS ONE, 2012, Vol. 7, no. 3, pp. 34400-34407.; Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA, 1997, Vol. 94, no. 7, pp. 3195-3199.; Zhao W., Xie W., Xiao Q., Beers D.R., Appel S.H. Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia. J. Neurochem., 2006, Vol. 99, no. 4, pp. 1176-1187.; https://www.mimmun.ru/mimmun/article/view/729
-
14Academic Journal
المؤلفون: A. V. Yovdiy, V. I. Shardakov, T. P. Zagoskina, E. L. Nazarova, M. N. Khorobrykh
المصدر: Медицинская иммунология, Vol 13, Iss 1, Pp 67-72 (2014)
مصطلحات موضوعية: non-hodgkin lymphoma, immune parameters, cytokines, Immunologic diseases. Allergy, RC581-607
Relation: https://www.mimmun.ru/mimmun/article/view/282; https://doaj.org/toc/1563-0625; https://doaj.org/toc/2313-741X; https://doaj.org/article/3843ca1b6bfa44a5af3ce8934d490d87
-
15
المؤلفون: I. Glot, I. Shardakov, A. P. Shestakov
المصدر: 14th WCCM-ECCOMAS Congress.
مصطلحات موضوعية: Vibration isolation, Computer science, Movement (music), Acoustics
-
16
المؤلفون: N Kosheleva, R Tsvetkov, I Shardakov
المصدر: Applied photonics. :324-335
مصطلحات موضوعية: Materials science, Strain (chemistry), Thermal, General Medicine, Fiber, Composite material, Compensation (engineering)
-
17Academic Journal
المؤلفون: N M Gurina, E P Svedentsov, V I Shardakov, V V Cherepanova
المصدر: Терапевтический архив, Vol 80, Iss 7, Pp 27-29 (2008)
مصطلحات موضوعية: vaccine prophylaxis, viral hepatitis b, acute leukemia, polychemotherapy, antibodie, Medicine
-
18
المؤلفون: M.N. Khorobrykh, N. A. Zorina, V. I. Shardakov, EL Nazarova, IV Paramonov, NV Minaeva, E. E. Sukhorukova
المصدر: Kliničeskaâ onkogematologiâ, Vol 11, Iss 1, Pp 54-69 (2018)
مصطلحات موضوعية: gene polymorphisms, Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Hematology, Hematopoietic stem cell transplantation, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, lcsh:RC254-282, immune response, multiple myeloma, Toll-like receptor, Genetic marker, Internal medicine, cytokine, autologous hematopoietic stem cell transplantation, medicine, business, Value (mathematics), high-dose chemotherapy, INDUCTION TREATMENT, Multiple myeloma
-
19
المؤلفون: I. Glot, D. Gubskiy, I. Shardakov, A. P. Shestakov
المصدر: PROCEEDINGS OF THE X ALL-RUSSIAN CONFERENCE “Actual Problems of Applied Mathematics and Mechanics” with International Participation, Dedicated to the Memory of Academician A.F. Sidorov and 100th Anniversary of UrFU: AFSID-2020.
مصطلحات موضوعية: Vibration, Physics, Vibration isolation, Orientation (geometry), Rigidity (psychology), Mechanics, Center of mass, Impulse (physics), Rigid body dynamics, Damper
-
20
المؤلفون: I. Shardakov, V. Yepin, A. P. Shestakov, R. Tsvetkov, G. Gusev, I. Glot
المصدر: MECHANICS, RESOURCE AND DIAGNOSTICS OF MATERIALS AND STRUCTURES (MRDMS-2020): Proceeding of the 14th International Conference on Mechanics, Resource and Diagnostics of Materials and Structures.
مصطلحات موضوعية: Vibration, Computer science, business.industry, Structure (category theory), Structural engineering, Reinforced concrete, business